Request for Covid-19 Impact Assessment of this Report
Agilent Technologies
Bio-Rad Laboratories
Illumina
Sequenom
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Type I
Type II
Type III
Split by applications, this report focuses on sales, market share and growth rate of Prenatal Genetic Testing in each application, can be divided into
Application 1
Application 2
Application 3
United States Prenatal Genetic Testing Sales Market Report 2021
1 Prenatal Genetic Testing Overview
1.1 Product Overview and Scope of Prenatal Genetic Testing
1.2 Classification of Prenatal Genetic Testing
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Applications of Prenatal Genetic Testing
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 USA Market Size (Value and Volume) of Prenatal Genetic Testing (2011-2021)
1.4.1 USA Prenatal Genetic Testing Sales, Revenue and Price (2011-2021)
1.4.2 USA Prenatal Genetic Testing Sales and Growth Rate (2011-2021)
1.4.3 USA Prenatal Genetic Testing Revenue and Growth Rate (2011-2021)
2 USA Prenatal Genetic Testing Competition by Manufacturers
2.1 USA Prenatal Genetic Testing Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 USA Prenatal Genetic Testing Revenue and Share by Manufactures (2015 and 2016)
3 USA Prenatal Genetic Testing (Volume and Value) by Type
3.1 USA Prenatal Genetic Testing Sales and Market Share by Type (2011-2021)
3.2 USA Prenatal Genetic Testing Revenue and Market Share by Type (2011-2021)
4 USA Prenatal Genetic Testing (Volume) by Application
5 USA Prenatal Genetic Testing Manufacturers Analysis
5.1 Agilent Technologies
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Prenatal Genetic Testing Product Type and Technology
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 Prenatal Genetic Testing Sales, Revenue, Price of Agilent Technologies (2015 and 2016)
5.2 Bio-Rad Laboratories
5.2.1 Company Basic Information,Manufacturing Base and Competitors
5.2.2 Pharma & Healthcare Product Type and Technology
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 Pharma & Healthcare Sales, Revenue, Price of Bio-Rad Laboratories (2015 and 2016)
5.3 Illumina
5.3.1 Company Basic Information,Manufacturing Base and Competitors
5.3.2 Illumina Product Type and Technology
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 Illumina Sales, Revenue, Price of Illumina (2015 and 2016)
5.4 Sequenom
5.4.1 Company Basic Information,Manufacturing Base and Competitors
5.4.2 Product Type and Technology
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 Sequenom Sales, Revenue, Price of Sequenom (2015 and 2016)
6 Prenatal Genetic Testing Technology and Development Trend
6.1 Prenatal Genetic Testing Technology Analysis
6.2 Prenatal Genetic Testing Technology Development Trend
7 Research Findings and Conclusion
Figure Picture of Prenatal Genetic Testing
Table Classification of Prenatal Genetic Testing
Figure USA Sales Market Share of Prenatal Genetic Testing by Type in 2015
Table Applications of Prenatal Genetic Testing
Figure USA Sales Market Share of Prenatal Genetic Testing by Application in 2015
Table USA Prenatal Genetic Testing Sales, Revenue and Price (2011-2021)
Figure USA Prenatal Genetic Testing Sales and Growth Rate (2011-2021)
Figure USA Prenatal Genetic Testing Revenue and Growth Rate (2011-2021)
Table USA Prenatal Genetic Testing Sales of Key Manufacturers (2015 and 2016)
Table USA Prenatal Genetic Testing Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Prenatal Genetic Testing Sales Share by Manufacturers
Figure 2016 Prenatal Genetic Testing Sales Share by Manufacturers
Table USA Prenatal Genetic Testing Revenue by Manufacturers (2015 and 2016)
Table USA Prenatal Genetic Testing Revenue Share by Manufacturers (2015 and 2016)
Table 2015 USA Prenatal Genetic Testing Revenue Share by Manufacturers
Table 2016 USA Prenatal Genetic Testing Revenue Share by Manufacturers
Table USA Prenatal Genetic Testing Sales and Market Share by Type (2011-2021)
Table USA Prenatal Genetic Testing Sales Share by Type (2011-2021)
Figure Sales Market Share of Prenatal Genetic Testing by Type (2011-2021)
Figure USA Prenatal Genetic Testing Sales Growth Rate by Type (2011-2021)
Table USA Prenatal Genetic Testing Revenue and Market Share by Type (2011-2021)
Table USA Prenatal Genetic Testing Revenue Share by Type (2011-2021)
Figure Revenue Market Share of Prenatal Genetic Testing by Type (2011-2021)
Figure USA Prenatal Genetic Testing Revenue Growth Rate by Type (2011-2021)
Table USA Prenatal Genetic Testing Sales and Market Share by Application (2011-2021)
Table USA Prenatal Genetic Testing Sales Share by Application (2011-2021)
Figure Sales Market Share of Prenatal Genetic Testing by Application (2011-2021)
Figure USA Prenatal Genetic Testing Sales Growth Rate by Application (2011-2021)
Table Agilent Technologies Basic Information List
Table Prenatal Genetic Testing Sales, Revenue, Price of Agilent Technologies (2015 and 2016)
Table Bio-Rad Laboratories Basic Information List
Table Prenatal Genetic Testing Sales, Revenue, Price of Bio-Rad Laboratories (2015 and 2016)
Table Illumina Basic Information List
Table Prenatal Genetic Testing Sales, Revenue, Price of Illumina (2015 and 2016)
Table Sequenom Basic Information List
Table Prenatal Genetic Testing Sales, Revenue, Price of Sequenom (2015 and 2016)
Biomaterials are materials of either synthetic or natural origin that are used for interaction with biological systems for medical purposes such as treating or repairing damage tissues. They are used in joint replacements, plastic surgeries, drug delivery devi...
The global DNA sequencing market was estimated to be $6,243 million in 2017 and is projected to reach $25,470 million in 2025 growing with a CAGR of 19% from 2018 to 2025. DNA sequencing is a type of technology in which several DNA strands can be sequenced through massive parallelization. The DNA sequencing contains both Sanger’s method of sequencing and non-Sanger’s methods of sequencing. ...
Patients with serious nervous system injuries or strokes often require lifelong assistance, which burdens patients, their families, and society. Innovative, paradigm shifting strategies are required to develop treatments for neurological injury. Early dia...